Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation

Liver Transplantation

Volumn 20, Issue 12, 2014, Pages 1454-1461

  Wong, Robert J ^a,b   Gish, Robert G ^c,d   Ahmed, Aijaz ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Robert G Gish Consultants   (United States)

^d HEPATITIS B FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASIAN; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HISPANIC; HOSPITAL ADMISSION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; REGISTRATION; RETROSPECTIVE STUDY; SURVIVAL; UNITED STATES; COMPLICATION; DISEASE COURSE; END STAGE LIVER DISEASE; MIDDLE AGED; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; DISEASE PROGRESSION; END STAGE LIVER DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 84912071410     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23981     Document Type: Article

References (27)

1. Hoyert DL, Xu J,. Deaths: Preliminary data for 2011. Natl Vital Stat Rep 2012; 61 (6): 1-51.
2. D'Amico G, Garcia-Tsao G, Pagliaro L,. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.
3. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128.
4. Merkel C, Bolognesi M, Angeli P, Noventa F, Caregaro L, Sacerdoti D, Gatta A,. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 1989; 84: 717-722.
5. Taniguchi M,. Liver transplantation in the MELD era-analysis of the OPTN/UNOS registry. Clin Transpl 2012; 2012: 41-65.
6. Freeman RB, Edwards EB, Harper AM,. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006; 6: 1416-1421.
7. Goldberg D, French B, Trotter J, Shetty K, Schiano T, Reddy KR, Halpern SD,. Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation 2013; 96: 211-216.
8. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
9. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
10. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026.
11. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-810.
12. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA,. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32-39.
13. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-1660.
14. Yoo HY, Edwin D, Thuluvath PJ,. Relationship of the Model for End-Stage Liver Disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003; 98: 1395-1399.
15. Stewart CA, Malinchoc M, Kim WR, Kamath PS,. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007; 13: 1366-1371.
16. Ham J, Gish RG, Mullen K,. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy. Liver Transpl 2006; 12 (suppl 3): S102-S104.
17. Milani A, Marra L, Siciliano M, Rossi L,. Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach. Hepatogastroenterology 1985; 32: 270-272.
18. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR,. Model for end-stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903.
19. Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ Jr, Goldman L, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997; 113: 1278-1288.
20. del Olmo JA, Peña A, Serra MA, Wassel AH, Benages A, Rodrigo JM,. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000; 32: 19-24.
21. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-689.
22. Child CG, Turcotte JG,. Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia, PA: W.B. Saunders; 1964.
23. Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI,. Current concepts in the assessment and treatment of hepatic encephalopathy. QJM 2010; 103: 9-16.
24. Atterbury CE, Maddrey WC, Conn HO,. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398-406.
25. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
26. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H,. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773.
27. Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-885.